HOME ABOUT US TECHNOLOGY PRODUCTS CONTACT US  
 
       
 
 

News
   
  About Us
  Career Opportunities
  Directions
  News
     


March 29, 2011
BioHelix is conducting clinical study with its first in vitro diagnostic product, the IsoAmp® HSV assay

BEVERLY, Mass - Herpes simplex viruses (HSV) are a common human pathogen found worldwide that cause a variety of diseases, including viral meningitis, skin infection, genital herpes, and neonatal herpes. Herpes simplex viruses have been categorized into two different serotypes: HSV-1 is generally associated with infections in the tongue, month, lips, pharynx and eyes; whereas HSV-2 is primarily associated with genital and neonatal infections.  Traditional techniques used for the detection of HSV-1 and HSV-2 in lesions require a viral culture. The cell culture procedure takes a minimum of 16 hours to detect HSV and also requires a cell culture facility.

The IsoAmp® HSV Assay utilizes BioHelix’s proprietary HDA isothermal amplification technology and a self-contained disposable detection cassette for detection of HSV DNA within 1.5 hours obtaining the specimens. The IsoAmp® HSV Assay is currently undergoing a multi-center clinical study in the U.S. to compare its performance with a standard cell culture method. The company expects to complete the clinical study by the end of April.

For more information on IsoAmp® HSV Assay

 
<<Back to News
         
Privacy, Limitation, Warranty, Disclaimer